Get started
Live feed
·
PRReleasevia Quantisnow
Ironwood Pharmaceuticals Inc. logo

Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand

ByQuantisnow·Wall Street's wire, on your screen.
IRWDIronwood Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRWD (Ironwood Pharmaceuticals Inc.) and more on Quantisnow.